Concentra Group Holdings Parent/$CON
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Concentra Group Holdings Parent
Concentra Group Holdings Parent Inc is a provider of occupational health services in the USA. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
- Ticker
- $CON
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 9,983
- Headquarters
- Addison, United States
- Website
- www.concentra.com
CON Metrics
BasicAdvanced
$4.9B
25.23
$1.53
0.62
$0.25
0.65%
Price and volume
Market cap
$4.9B
Beta
0.62
52-week high
$39.60
52-week low
$18.55
Average daily volume
1.1M
Dividend rate
$0.25
Financial strength
Current ratio
1.377
Quick ratio
1.244
Long term debt to equity
4.037
Total debt to equity
4.233
Dividend payout ratio (TTM)
16.13%
Interest coverage (TTM)
3.56%
Profitability
EBITDA (TTM)
461.607
Gross margin (TTM)
29.31%
Net profit margin (TTM)
8.69%
Operating margin (TTM)
16.69%
Effective tax rate (TTM)
23.15%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
8.16%
Return on equity (TTM)
47.06%
Valuation
Price to earnings (TTM)
25.233
Price to revenue (TTM)
2.151
Price to book
10.3
Price to tangible book (TTM)
-3.98
Price to free cash flow (TTM)
18.403
Free cash flow yield (TTM)
5.43%
Free cash flow per share (TTM)
2.094
Dividend yield (TTM)
0.65%
Forward dividend yield
0.65%
Growth
Revenue change (TTM)
14.02%
Earnings per share change (TTM)
29.39%
What the Analysts think about CON
Analyst ratings (Buy, Hold, Sell) for Concentra Group Holdings Parent stock.
Analyst projections of the future price of Concentra Group Holdings Parent stock.
Bulls say / Bears say
Concentra grew Q2 revenue by 10% and adjusted EBITDA by 22.5%, then raised its full-year 2026 revenue and EBITDA guidance. This points to strong execution and improving earnings momentum. (Concentra)
Core revenue excluding the Pivot acquisition rose 8% in Q2, with daily visits up 2.6% and revenue per visit up 4.6%. That suggests underlying demand and pricing, rather than acquisitions alone, are supporting growth. (The Motley Fool)
Onsite clinic revenue grew 27.9% organically in Q2 excluding Pivot, and management said its pipeline of new opportunities remained strong. This faster-growing channel gives Concentra room to expand beyond its established centres. (The Motley Fool)
Work-comp revenue per visit benefited from fee increases and a shift towards higher-paying initial injury visits. Management expects rate growth to move closer to 3% for the rest of 2026, which could temper revenue growth. (The Motley Fool)
Concentra warns that reimbursement increases may not keep pace with cost inflation, while labour shortages or higher staff costs could add pressure. If costs outstrip reimbursement, margins may narrow. (Concentra)
Concentra had $1.57 billion of debt and a net leverage ratio of 2.99x at the end of Q2. That leaves meaningful balance-sheet exposure and means acquisitions, shareholder returns and debt reduction compete for cash. (Concentra, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2026.
CON Financial Performance
Revenues and expenses
CON Earnings Performance
Company profitability
Upcoming events
No upcoming events
CON News
AllArticlesVideos
Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
Business Wire10 hours ago
Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
Business Wire2 weeks ago
Why Concentra's Quiet Healthcare Business Keeps Winning
MarketBeat2 weeks ago
Funds containing CON
AllUSDGBPEUR
Fund name | Fund size | $CON weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.27% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.27% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.15% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.15% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.06% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.